Audiology Worldnews·Industry news·Business & finance·3w agoGN takes DKK182m (€24.4m) hit as LXE investment is written offThe write-off and planned separation of GN's Hearing division signal ongoing consolidation pressures and strategic uncertainty at one of audiology's largest manufacturers, which could affect product pipelines and market competition.
MedWatch·Industry news·Business & finance·4w agoGN must swallow major loss on stake in US audio company: “Unfortunate and frustrating”The write-off highlights the financial risks major hearing aid manufacturers face when investing in emerging audio-tech partners, and may affect GN's future R&D and partnership strategy.＋Save
Hearing Review·Industry news·Business & finance·2mo agoLXE Hearing Announces Wind-Down of US Operations, Affecting Eargo, Lexie, and Go BrandsThe collapse of LXE Hearing removes several prominent direct-to-consumer and OTC hearing aid brands from the US market simultaneously, potentially disrupting care for a large number of existing device users and reshaping the competitive OTC landscape.＋Save
Hearing Tracker·Industry news·Business & finance·2mo agoEargo and Lexie Parent LXE Hearing Begins U.S. Wind-Down; Support Beyond Sept. 15 UncertainThe collapse of a major direct-to-consumer hearing aid company affects thousands of existing device users and signals continued fragility in the OTC and DTC hearing aid market.＋Save
Hearing Tracker·Industry news·OTC / consumer·11mo agoLexie H1 Hearing Buds: Wireless OTC Hearing Aids for $299The wind-down of LXE Hearing removes three of the most visible budget OTC hearing aid brands from the U.S. market, reshaping the competitive landscape for both OTC and traditional clinic-dispensed devices.＋Save
